Leading to Answers...Science For Life

Colleagues: it is with tremendous excitement that I look forward to the coming year in the life of our society. Together, we have much to accomplish.

As President of the SRS, it will be my privilege to regularly communicate with the membership through a series of letters published in the society's official journal: Nuclear Medicine and Biology, which is published eight times per year. These messages will be made available online as each issue is published and will also be archived here for your future reference.

SRS Journal
Nuclear Medicine and Biology is the official journal of SRS. Join SRS today and receive your complimentary subscription.   learn more
SRS Awards
Consistent with its mission, the SRS provides support in the form of bursaries for students and post-doctoral fellows.   learn more

Resources and Links

MICAD


The Molecular Imaging and Contrast Agent Database (MICAD) is an online source of information on in vivo molecular imaging agents based on recommendations from the extramural community.   click here

Current Announcement

Links


Newsletter

The 20th International Symposium on
Radiopharmaceutical Sciences

May 12-17, 2013
ICC JEJU, Jeju South Korea

The Society of Radiopharmaceutical Sciences cordially invites you to attend the 20th International Symposium on Radiopharmaceutical Sciences in Jeju South Korea.

To learn more about the meeting and the beautiful island of Jeju, please visit the symposium website. learn more


ISRS 2013 Key Dates

  • Abstract Submission: 10/16/2012

  • On-line registration Open: 10/16/2012

  • Abstract Submission: 12/18/2012

  • Abstract Acceptance: 02/19/2013

  • Early-Registration: 03/12/2013

  • Pre-Registration: 04/09/2013

About SRS

The SRS is an international society providing academic and intellectual support for radiopharmaceutical science.

The SRS is a multidisciplinary professional organization dedicated to the advancement of excellence in education and research in radiopharmaceutical science and in the study and use of radiopharmaceuticals.